Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Guidelines search
Search Guidelines
Guidelines search
Apply
Filters
Close
HIV Clinical Guidelines: Adult and Adolescent ARV
(61)
HIV Clinical Guidelines: Adult and Adolescent ARV
(61)
HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections
(64)
HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections
(64)
HIV Clinical Guidelines: Pediatric ARV
(86)
(-)
HIV Clinical Guidelines: Pediatric ARV
(86)
HIV Clinical Guidelines: Pediatric Opportunistic Infections
(44)
HIV Clinical Guidelines: Pediatric Opportunistic Infections
(44)
Perinatal HIV Clinical Guidelines
(93)
Perinatal HIV Clinical Guidelines
(93)
Guidelines for Caring for People With HIV Displaced by Disasters
(4)
Guidelines for Caring for People With HIV Displaced by Disasters
(4)
Archived Guidelines
(8)
Archived Guidelines
(8)
Search Results
21 – 40
of
86
Hematologic Effects
Hepatic Events
Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus
Lactic Acidosis
Lipodystrophies and Weight Gain
Nephrotoxic Effects
Osteopenia and Osteoporosis
Rash and Hypersensitivity Reactions
Management of Children Receiving Antiretroviral Therapy
Overview
Modifying Antiretroviral Regimens in Children With Sustained Virologic Suppression on Antiretroviral Therapy
Recognizing and Managing Antiretroviral Treatment Failure
Antiretroviral Treatment Interruption in Children With HIV
Appendix A: Pediatric Antiretroviral Drug Information
Overview
Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)
Abacavir
Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)
Protease Inhibitors (PIs)
Atazanavir
Pagination
First page
‹‹
Previous page
‹
Page
1
Current page
2
Page
3
Page
4
Page
5
Next page
›
Last page
››